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ABSTRACT The highly virulent Francisella tularensis subsp. tularensis has been classiﬁed as a category A bioterrorism agent. A
livevaccinestrain(LVS)hasbeendevelopedbutremainsunlicensedintheUnitedStatesbecauseofanincompleteunderstand-
ingofitsattenuation.Lipopolysaccharide(LPS)modiﬁcationisacommonstrategyemployedbybacterialpathogenstoavoid
innate immunity. A novel modiﬁcation enzyme has recently been identiﬁed in F. tularensis and Helicobacter pylori. This en-
zyme,atwo-componentKdo(3-deoxy-D-manno-octulosonicacid)hydrolase,catalyzestheremovalofasidechainKdosugar
fromLPSprecursors.Thebiologicalsigniﬁcanceofthismodiﬁcationhasnotyetbeenstudied.Toaddresstheroleofthetwo-
component Kdo hydrolase KdhAB in F. tularensis pathogenesis, a kdhAB deletion mutant was constructed from the LVS
strain.Inintranasalinfectionofmice,the kdhABmutantstrainhada50%lethaldose(LD50)2log10unitshigherthanthatof
theparentalLVSstrain.Thelevelsoftheproinﬂammatorycytokinestumornecrosisfactoralpha(TNF-)andinterleukin-1
(IL-1)inbronchoalveolarlavageﬂuidweresigniﬁcantlyhigher(2-fold)inmiceinfectedwiththe kdhABmutantthaninmice
infected with LVS. In vitro stimulation of bone marrow-derived macrophages with the kdhAB mutant induced higher levels of
TNF-andIL-1inaTLR2-dependentmanner.Inaddition,TLR2/miceweremoresusceptiblethanwild-typemiceto
kdhABbacterialinfection.Finally,immunizationofmicewith kdhABbacteriaelicitedahighlevelofprotectionagainstthe
highly virulent F. tularensis subsp. tularensis strain Schu S4. These ﬁndings suggest an important role for the Francisella Kdo
hydrolasesysteminvirulenceandofferanovelmutantasacandidatevaccine.
IMPORTANCE Theﬁrstlineofdefenseagainstabacterialpathogenisinnateimmunity,whichslowstheprogressofinfectionand
allows time for adaptive immunity to develop. Some bacterial pathogens, such as Francisella tularensis, suppress the early innate
immune response, killing the host before adaptive immunity can mature. To avoid an innate immune response, F. tularensis
enzymaticallymodiﬁesitslipopolysaccharide(LPS).AnovelLPSmodiﬁcation—Kdo(3-deoxy-D-manno-octulosonicacid)sac-
charide removal—has recently been reported in F. tularensis. We found that the kdhAB mutant was signiﬁcantly attenuated in
mice. Additionally, the mutant strain induced an early innate immune response in mice both in vitro and in vivo. Immunization
of mice with this mutant provided protection against the highly virulent F. tularensis strain Schu S4. Thus, our study has identi-
ﬁedanovelLPSmodiﬁcationimportantformicrobialvirulence.Amutantlackingthismodiﬁcationmaybeusedasaliveattenu-
atedvaccineagainsttularemia.
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F
rancisellatularensis,oneofthedeadliestrespiratorypathogens
in existence, is considered a potential biological weapon be-
cause it is readily aerosolized and exhibits a high degree of infec-
tivity and lethality in humans. An attenuated live vaccine strain
(LVS) has been developed but has not been licensed as a vaccine
because of an incomplete understanding of the basis for its atten-
uatedvirulenceandassociatedsideeffects.Therehasbeenawide-
spread research effort aimed at elucidating Francisella pathogen-
esis and identifying components for rational vaccine design.
F. tularensis is a successful pathogen that can evade and suppress
innate immune responses. After intranasal infection of mice,
F.tularensisinitiallycolonizesthelung,infectingseveralcelltypes
but failing to stimulate proinﬂammatory cytokine production for
the ﬁrst 2 to 3 days (1–5). This initial delay in inﬂammation con-
tributestotheabilityofF.tularensistoreplicateinthelung,spread
into systemic organs, and cause sepsis leading to the host’s death
(4). To suppress the early proinﬂammatory cytokine response,
F. tularensis employs a variety of strategies, such as avoiding dis-
closure of itself to the innate immune system (6, 7).
Lipopolysaccharide (LPS) of F. tularensis plays a signiﬁcant
role in evasion of host immune responses (8–11). LPS, the major
component of Gram-negative bacterial outer membranes (12,
13), itself has three components: (i) lipid A, a glucosamine-based
glycolipid; (ii) a core oligosaccharide ketosidically linked to lipid
A by an eight-carbon sugar, 3-deoxy-D-manno-octulosonic acid
(Kdo); and (iii) the O-antigen polysaccharide comprising multi-
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many bacterial species such as Escherichia coli is a powerful stim-
ulantofToll-likereceptor4(TLR4)-mediatedinnateimmunere-
sponses. In contrast, F. tularensis lipid A triggers no TLR-
mediated innate response because of a number of key structural
modiﬁcations (9); speciﬁcally, despite initial similarity to E. coli
lipid A, the lipid A precursor of F. tularensis undergoes dephos-
phorylation, deacylation, and carbohydrate incorporation that
render the molecule undetectable by the TLR4 receptor. Differ-
ences in the length of the fatty acid chain of lipid A (16 to 18
carbonsforF.tularensisasopposedto12to14carbonsforE.coli)
further enhance the ability of F. tularensis to evade TLR4-
mediated innate immunity. These modiﬁcations contribute to
bacterial virulence (8, 10).
A novel LPS-modifying two-component KdhAB Kdo hydro-
lase enzyme complex has recently been identiﬁed in F. tularensis
(14,15).AcoreLPSprecursorcontainingtwoKdoresiduesisﬁrst
synthesized. One Kdo in the backbone of the core polysaccharide
is ketosidically linked to lipid A and glycosidically linked to the
remainderofthecorepolysaccharide,andthesecondKdoresidue
is glycosidically attached as a side chain. KdhAB removes the side
chain Kdo, leaving an LPS molecule containing only one Kdo
residue (Fig. 1) (14–16). The KdhAB Kdo hydrolase is a two-
component enzyme composed of a sialidase-like protein (the cat-
alytic subunit) and a small inner membrane protein (perhaps a
membrane-anchoring subunit) (15). This novel enzyme complex
has been reported in two other pathogens, Helicobacter pylori and
Legionellapneumophila(14,17,18).Itsbiologicalsigniﬁcance—in
particular, its role in pathogenicity—has not yet been investi-
gated. Here, we show that the F. tularensis kdhAB LVS mutant is
attenuated in a mouse model of infection and stimulates—in a
TLR2-dependentmanner—astrongerproinﬂammatorycytokine
response than the parental LVS. Furthermore, immunization of
mice with the kdhAB mutant provides signiﬁcant protection
against fully virulent F. tularensis type A strain Schu S4.
RESULTS
TheF.tularensisLVSkdhABmutantisattenuatedinmice.To
fully evaluate the importance of the KdhAB Kdo hydrolase in the
virulence of F. tularensis LVS, kdhA and kdhB genes were deleted
byhomologousrecombinationinanLVSbackground,givingrise
to the kdhAB mutant. Previously described analysis by high-
performance anion-exchange chromatography (HPAEC) (14)
conﬁrmedthat,unliketheLPSofparentalLVS,whichhasasingle
Kdoresidue,theLPSofthekdhABmutanthastwoKdoresidues
(Fig. 1; see Table S1 in the supplemental material).
To evaluate the role of Kdo hydrolase activity in F. tularensis
virulence, we infected BALB/cByJ mice with graded doses of LVS
or the kdhAB mutant via the intranasal route. All mice chal-
lenged with 103 CFU of LVS succumbed to the infection within
9 days (Fig. 2A). In contrast, all mice challenged with a similar
dose of the kdhAB mutant survived (Fig. 2A). At a dose of
105CFUofthekdhABmutant,17%oftheinfectedmicesurvived
(Fig. 2A).
TheobservedphenotypesinthekdhABmutantweresuccess-
fully complemented with the pkdhAB plasmid carrying the kdhA
and kdhB genes. LPS analysis showed that the complemented
strainhadonlyasingleKdoresidueinitscoreLPS(seeTableS1in
the supplemental material). In addition, complementation of
kdhAB restored virulence to the wild-type (WT) level. The sur-
vival rates of BALB/cByJ mice (10 mice in each group) 28 days
after an intranasal challenge with 5  103 F. tularensis LVS or a
kdhABmutantharboringeitheravectorcontrol(pFNLTP6)ora
plasmid carrying kdhAB genes (pkdhAB) were as follows: 0% for
mice infected with LVS, 100% for mice infected with the kdhAB
mutant carrying pFNLTP6, and 20% for mice infected with the
kdhAB mutant carrying pkdhAB. These data indicate that Kdo
hydrolase activity is important for the virulence of F. tularensis
LVS.
We also examined the ability of the kdhAB mutant to colo-
nizethelungandtodisseminateintootherorgansafterintranasal
challenge of mice. Six days after infection with 103 bacteria, both
parentalLVSanditskdhABmutanthadreachedasimilarlevelof
colonization in the lungs, with counts of 3  106 CFU/g and
107 CFU/g, respectively (Fig. 2B). However, the numbers of
kdhAB mutant bacteria in spleen, liver, and blood were 1.5 to 3
logarithmic units lower than the numbers of LVS bacteria
(Fig.2B)(Student’sttest,P0.05).Overall,theseresultsindicate
that the kdhAB mutant is deﬁcient in its ability to disseminate
systemically.
To determine whether the observed defect in dissemination is
related to bacterial growth kinetics, growth rates were compared
under different conditions. There was no difference in growth
between LVS and the kdhAB mutant when bacteria were cul-
turedinbrothmediumorinJ774A.1macrophage-likeandMH-S
alveolar macrophage-like cell lines (see Fig. S1A and S1B in the
supplemental material). Moreover, the kdhAB mutant was not
sensitive to complement-mediated killing (Fig. S1C). Therefore,
the defect of the kdhAB mutant in dissemination to systemic
organs was not due to a growth defect or to serum sensitivity.
The cytokine response to the F. tularensis LVS kdhAB mu-
tant is enhanced. Within the ﬁrst day after infection, mutants of
F. tularensis that cannot modify their lipid A elicit a stronger pro-
inﬂammatory response than parental LVS did (8, 19). Since the
KdhAB hydrolase is involved in the modiﬁcation of the LPS core
oligosaccharide but not in the modiﬁcation of lipid A, we com-
pared the proinﬂammatory responses to LVS and the kdhAB
mutant. To this end, mice were challenged intranasally with
103 CFU of either LVS or the kdhAB mutant, and the levels of
tumor necrosis factor alpha (TNF-) and interleukin-1 (IL-1)
in samples of bronchoalveolar lavage (BAL) ﬂuid were deter-
mined in an enzyme-linked immunosorbent assay (ELISA). Con-
sistentwithpreviousreports(6),thelevelsofTNF-andIL-1in
FIG 1 LPSs from F. tularensis LVS and kdhAB mutant strain differ from
each other by a side chain Kdo. The structure of core oligosaccharide synthe-
sized by LVS (55) and the proposed structure of core oligosaccharide synthe-
sized by the kdhAB mutant, as determined by HPAEC (14), are shown.
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fromthoseincontrolmicegivenphosphate-bufferedsaline(PBS)
(Fig. 3A, left panel). In contrast, the levels of TNF- and IL-1
were signiﬁcantly higher (~2-fold) in mice infected by the
kdhAB mutant than in mice infected by LVS or control mice
given PBS (Fig. 3A, left panel). The stronger proinﬂammatory
response was not due to differences in bacterial burden, as the
numbers of kdhAB and LVS bacteria in the lungs were similar
(Fig. 3A, right panel). Therefore, in contrast to LVS, the kdhAB
mutant elicited an early proinﬂammatory response that was de-
tected 24 h after infection.
To test whether the in vivo cytokine response also differs in ex
vivo macrophages, bone marrow-derived macrophages (BMMs)
from C57BL/6J mice were infected at different multiplicities of
infection (MOIs) with either LVS or the kdhAB mutant. Super-
natants were collected after 24 h, and secretion of TNF- and
IL-1 was measured by ELISA. At all MOIs tested, TNF- secre-
tion by BMMs stimulated by the kdhAB mutant was higher by a
factor of at least 2 than that by BMMs stimulated by LVS (Fig. 3B,
left panel). Results were similar for IL-1 secretion (Fig. 3B, right
panel). Consistent with the cytokine secretion proﬁle, the expres-
sion of TNF- and IL-1 genes was higher in kdhAB mutant-
stimulated BMMs than in LVS-stimulated BMMs (Fig. 3C).
TheF.tularensisLVSkdhABmutantactivatestheTLR2sig-
naling pathway. To investigate the basis for the enhanced innate
immune response to the kdhAB mutant, we assessed the re-
sponses of murine macrophage-like cell lines in which various
TLRsignalingpathwayswereinactivated.Cellswereinfectedwith
eitherLVSorthekdhABmutantatanMOIof100andlysed24h
later for measurement of IL-1. Cell activation was calculated as
the IL-1 ratio in infected cells versus uninfected cells. LVS bac-
teriaelicitedaproinﬂammatoryresponseinWT,Unc93B/,and
TLR4/ cells, but not in MyD88/ or TLR2/ cells (Fig. 4A).
These data are in agreement with previous reports that the innate
immune response to LVS is mediated through TLR2 signaling (3,
20).Interestingly,thekdhABmutantshowedasimilarpatternof
activation,aresultindicatingthatTLR2—butnotTLR3,-4,-7,or
-9—mediates the innate immune response to kdhAB mutant
bacteria. Moreover, the proinﬂammatory response was signiﬁ-
cantly greater in kdhAB mutant-infected cells than in LVS-
infected cells (Fig. 4A). Control experiments conﬁrmed that WT
cells and knockout cells for Unc93B (required for TLR3, TLR7,
and TLR9 signaling), MyD88, TLR4, and TLR2 responded to var-
ious TLR agonists as expected (data not shown).
To assess whether kdhAB mutant-mediated enhancement of
the proinﬂammatory cytokine response is likely to be due to an
increase in nuclear factor B (NF-B) activation, we used
HEK293 cells expressing TLR2 (HEK-TLR2) or TLR4 and MD2
(HEK-TLR4/MD2). The stable cell lines were transiently trans-
fected with the reporter plasmid pNFB-luc, which expresses a
ﬁreﬂy luciferase gene under control of an NF-B promoter, and
wereincubatedwithLVSorkdhABorganisms.Reporteractivity
in HEK-TLR4/MD2 cells incubated with bacteria of either strain
did not differ (Fig. 4B). On the other hand, reporter activity in-
creased slightly but signiﬁcantly in HEK-TLR2 cells stimulated
with the kdhAB mutant over that in HEK-TLR2 cells stimulated
with LVS (P  0.05) (Fig. 4B). Control experiments using E. coli
LPS and Pam3CSK, known TLR4 and TLR2 antagonists, respec-
tively, showed high NF-B reporter activity as expected (Fig. 4B).
MechanisticbasisforactivationofTLR2bythekdhABmu-
tant.OnepossibleexplanationfortheincreaseinTLR2-mediated
NF-B activity is that, unlike WT LVS LPS, the mutant LPS pro-
duced by the kdhAB mutant is a TLR2 agonist (9). To test this
hypothesis, we assessed puriﬁed LPS preparations from each
strain for their ability to activate NF-B in HEK-TLR2 cells. LPS
fromLVSandthekdhABmutantshowedsimilarlevelsofNF-B
reporter activity, which was also similar to that elicited by whole
LVS organisms (Fig. 4B). Additionally, BMMs did not respond to
LPSfromeitherLVSorthekdhABmutantbysecretionofTNF-
and IL-1 when the puriﬁed LPS was tested at concentrations of
50, 250, 1,250, and 10,000 ng/ml (see Fig. S2 in the supplemental
material). Taken together, these results show that the kdhAB
mutant elicits stronger NF-B activation in a TLR2-dependent
manner, with a consequently greater proinﬂammatory response.
However, the greater proinﬂammatory response induced by the
mutant LPS probably is not due to activation of TLR2 by the
mutant LPS per se, as the LPS of the kdhAB mutant alone does
not trigger TLR2 signaling in vitro.
To further investigate the mechanism for enhanced TLR2 sig-
naling by the kdhAB mutant, we evaluated bacterial membrane
integrity. A leaky cell membrane caused by kdhAB mutation
would potentially release TLR2 ligands into the culture superna-
tanttobedetectedbyhostcells.Thus,thegrowthbehaviorsofLVS
and the kdhAB mutant were tested in the presence of SDS and
EDTA, agents that inhibit growth of bacterial cells with defective
outer membranes. The similar growth characteristics of the two
FIG 2 The virulence of the F. tularensis LVS kdhAB mutant strain is atten-
uated in mice. (A) Survival of mice after F. tularensis intranasal challenge.
BALB/cByJ mice (n  6) were challenged intranasally with LVS (103 CFU) or
kdhAB bacteria (103,1 0 4,o r1 0 5 CFU). (B) Bacterial burden in lung, spleen,
liver, and blood of mice 6 days after infection. BALB/cByJ mice (n  3) were
challenged intranasally with LVS bacteria (103 CFU) or kdhAB bacteria
(103CFU).
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® mbio.asm.org 3FIG3 Enhanced proinﬂammatory cytokine response to the F. tularensis LVS kdhAB mutant strain. (A) BALB/cByJ mice (n  3) were challenged intranasally
withLVSbacteria(103CFU),kdhABbacteria(103CFU),orPBS(control).BALﬂuidwascollected24hafterinfection,andthelevelsofTNF-andIL-1were
measured by ELISA (left panel). The bacterial burden in lung was measured 24 h after infection (right panel). (B) Levels of TNF- and IL-1 released by ex vivo
BMMsafterstimulationwithLVSorkdhABbacteria(MOIof10,20,or50).CulturesupernatantswereanalyzedbyELISA24hafterinfection.(C)TNF-and
IL-1geneexpressioninBMMsinfectedwithLVSorkdhABbacteria(MOIof10).Geneexpressionwasmeasuredbyreal-timePCR,normalizedwithRPIIgene
expression, and reported as relative expression compared with that in uninfected macrophages. All data are presented as mean plus SD (error bars) values (n 
3).
Okan et al.
4
® mbio.asm.org January/February 2013 Volume 4 Issue 1 e00638-12strains (Fig. 5A) strongly supported the notion that the kdhAB
mutation does not compromise cell membrane integrity. In an
alternativeapproach,wetestedtheﬁlteredsupernatantsofLVSor
kdhAB cultures for their ability to activate BMMs in vitro. The
culture supernatants were concentrated by Centricon ﬁlter de-
vices and incubated with BMMs for 24 h. Macrophage activation
was measured by the release of TNF- and IL-6. While the addi-
tion of LPS or PAM3CSK (as positive controls) to the BMMs did
resultinsigniﬁcantactivationofthecells,littleactivationwasseen
after the addition of the LVS- or kdhAB mutant-conditioned
media(seeFig.S3inthesupplementalmaterial).Thesimilarlylow
levels of TNF- and IL-6 for both LVS and kdhAB organisms
suggestedthatthereisnoleakageofpotentialTLR2ligandsdueto
the kdhAB mutation.
Unabletodetectaleaky-membranephenotype,wenextinves-
tigatedchangesinbacterialLPSandcell-surfaceproteinavailabil-
ity. It has been proposed that fully formed LPS on the bacterial
surface plays a vital role in preventing the binding of serum com-
plement, antibodies, and receptors of the innate immune system
(21–24). Toward this end, the analysis of total LPS level and a
characteristic LPS banding pattern showed no difference between
LVS and the kdhAB mutant (Fig. 6A). Additionally, matrix-
assistedlaserdesorptionionizationtimeofﬂight(MALDI-TOF)
analysis of lipid A indicated that LVS and the kdhAB mutant
have similar lipid A mass values (Fig. 6B). Although the kdhAB
mutation does not affect the total LPS level or the characteristic
banding pattern of LPS, we thought it is possible that the addi-
tional Kdo—a negatively charged sugar—in the kdhAB mutant
alters the conformation of LPS molecules, thereby making other
surface constituents more accessible to TLR2 receptors. To test
this hypothesis, we evaluated the binding of FopA antibodies to
the FopA surface protein in vitro. Live bacteria were incubated
with mouse antibodies to FopA, and surface-bound antibodies
were analyzed by Western blotting. Consistent with a previous
study (24), fully formed LPS signiﬁcantly reduced the binding of
antibodies to the LVS bacterial surface, whereas wbtA mutant
LPS,whichisdevoidofOpolysaccharide,didnot(Fig.5B).Strik-
ingly, substantial binding of FopA antibodies to the kdhAB mu-
tant bacterial surface was found, and this result suggested that a
TLR2 ligand present on the bacterial cell surface would be poten-
tially exposed for detection by host immune-cell TLR2 receptors.
The accessibility of surface proteins might well explain the en-
hanced TLR2 signaling activity caused by the kdhAB mutation.
BiologicalimpactofTLR2activationbythekdhABmutant.
We next addressed the biological importance of the TLR2-
mediated response to kdhAB bacteria in a mouse infection
model. WT C57BL/6, TLR2/, and TLR4/ mice were infected
with various doses of the kdhAB mutant via the intranasal route
and monitored for survival. Most strikingly, at a dose of 104 CFU,
all WT and TLR4/ mice survived, while no TLR2/ mice sur-
vived(Table1).TheresultssuggestthatTLR2-mediatedresponses
play a signiﬁcant role in the survival of mice infected with the
F. tularensis kdhAB mutant strain. Thus, the association of Kd-
hABKdohydrolasewithenhancedTLR2-mediatedinﬂammation
pointstoacriticalroleforthisenzymecomplexinthevirulenceof
LVS.
Immunization with F. tularensis LVS kdhAB mutant pro-
tectsagainstthehighlyvirulentF.tularensisSchuS4strain.Im-
munization with LVS is protective against the fully virulent F. tu-
larensis type A strain Schu S4 in a mouse model of infection, and
this protection involves TLR2-dependent innate immunity (25–
27). However, even in low numbers, LVS retains signiﬁcant viru-
lence in mice. Our ﬁndings that the kdhAB mutant is further
attenuated and elicits enhanced TLR2 signaling led us to investi-
gate the protective capacity of this mutant strain as a live cell
vaccine.Tothisend,BALB/cByJmicewereimmunizedwiththree
intranasal doses of LVS, the kdhAB mutant, or (as a control)
PBS. Four weeks after the last dose, the mice were challenged via
the intranasal route with either LVS at a dose of 104 CFU (10 
LD50) or the Schu S4 strain at a dose of 10 CFU (10  LD50). All
mice that had been immunized with LVS survived LVS challenge,
whereasallcontrolmicethathadreceivedPBSsuccumbedwithin
9 days (Fig. 7A). The kdhAB mutant was also fully protective
against LVS challenge (Fig. 7A). Furthermore, as expected, LVS-
immunized mice survived the fully virulent Schu S4 challenge,
while all PBS-treated control mice succumbed within 7 days
(Fig. 7B). Strikingly, mice immunized with the kdhAB mutant
were well protected; 90% of these mice survived an otherwise le-
thal challenge with Schu S4. Histologic examination of the livers
from infected mice revealed that kdhAB mutant-immunized
mice had much less tissue necrosis after challenge with Schu S4
(Fig. 7C) than did PBS-treated control mice. The protection con-
ferredbythekdhABmutantwasalsoreﬂectedbylowerbacterial
loads in the livers, spleens, and lungs from mutant-immunized
FIG4 BacteriaoftheF.tularensisLVSkdhABmutantstrainactivateNF-B
through the TLR2 signaling pathway. (A) Macrophage-like cell lines were
stimulatedwithLVSorkdhABbacteriafor2h(MOI100).TheIL-1level
in cell lysates was assessed by ELISA. Measurements were expressed as fold
induction in infected versus uninfected cells (mean plus SD; n  3). (B)
HEK293 cells stably expressing TLR2 or TLR4/MD2 were transiently trans-
fectedwithanNF-Bluciferasereporterplasmidandstimulatedfor24hwith
LVS or kdhAB bacteria (MOI  20) or with Pam3CSK (1 g/ml) or E. coli
LPS (100 ng/ml) as positive controls. Puriﬁed LPSs from LVS or kdhAB
bacteria (5 g/ml) were tested in a mixture with soluble CD14 recombinant
protein(5g/ml).Thedataarereportedasrelativeluciferaseunitsandrepre-
sentfoldinductionofluciferaseactivityinthecelllysatecomparedwiththatin
unstimulated cells (mean plus SD; n  3).
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mice. The Schu S4 bacterial loads in organs were similar in LVS-
and kdhAB mutant-immunized mice. Finally, the levels of
Francisella-speciﬁcIgGantibodywereslightlyhigherintheseraof
kdhAB mutant-immunized mice compared to LVS-immunized
mice (Fig. 7E).
DISCUSSION
Evasionofinnateimmunityisakeyvirulencefactorforanumber
of pathogens, including F. tularensis (6, 7). To avoid detection by
pattern recognition receptors such as TLRs, F. tularensis modiﬁes
its lipid A through the action of enzymes such as 4=-phosphatase,
galactosamine transferase, and mannosyl transferase (8, 10). A
novel LPS modiﬁcation was hypothesized in F. tularensis and
H. pylori: the removal of side chain Kdo from Kdo2-lipid A pre-
cursors by a Kdo hydrolase (16, 17). Such a modiﬁcation was
recently conﬁrmed, and the genes coding for a two-component
KdohydrolasewereidentiﬁedinF.tularensisandH.pylori(14,15,
17, 18). The biological signiﬁcance of the Kdo hydrolase, which is
also expressed by L. pneumophila (14), remained to be addressed.
By screening an F. tularensis subsp. novicida transposon mutant
library, Weiss and colleagues showed that a kdhB transposon mu-
tant was attenuated in mice, but no further characterization has
been reported (28). Here we demonstrate that the two-
component Kdo hydrolase KdhAB is important in the pathoge-
nicityofF.tularensisLVSbacteriaandintheorganism’savoidance
of the TLR2-mediated immune response. We further show that a
Kdo hydrolase-deﬁcient mutant is protective against the fully vir-
ulentF.tularensistypeAstrainSchuS4.Suchprotectivecapacityis
obviously a key feature to be hoped for in an effective vaccine
strain.
The kdhAB deletion mutant, unable to remove side chain
KdofromitsLPS(Fig.1),wasimpairedinitsabilityto
kill mice after intranasal challenge (Fig. 2). This atten-
uation was not due to a growth defect or to sensitivity
tocomplement-mediatedkilling.InH.pylori,Kdohy-
drolase inactivation has downstream effects on subse-
quent steps in LPS biosynthesis, reducing the efﬁ-
ciency of lipid A modiﬁcation enzymes 4=-
phosphatase and 3=-O-deacylase and the amount of
fully extended O antigen (17). Both 4=-phosphatase
and O antigen are required for full virulence of F. tu-
larensis in mice (10, 19, 29). However, Kdo hydrolase
inactivation in F. tularensis LVS did not affect lipid A
or O-antigen biosynthesis (Fig. 6). Therefore, viru-
lence attenuation was not related to a defect in 4=-
phosphatase activity or O-antigen assembly.
The avoidance of the TLR response by modiﬁca-
tionsinlipidAstructurehasbeendescribedinanum-
ber of pathogens, including members of the genera
Salmonella, Yersinia, Pseudomonas, and Francisella (8,
10,30–32).ThesemodiﬁcationsincludelipidAdeacy-
lation,dephosphorylation,andglycosylation.Wethus
hypothesizedthatF.tularensisremovessidechainKdo
from LPS core oligosaccharide to avoid the triggering
of innate immunity. In agreement with this hypothe-
sis, the kdhAB mutant stimulated a stronger TLR2-
mediated proinﬂammatory response in macrophage
monolayersthantheparentalLVSdid(Fig.3and4).In
vivo, kdhAB bacteria induced a proinﬂammatory re-
sponse in the lungs 24 h after intranasal challenge, while LVS
bacteria did not (Fig. 3A, left panel). Attenuation of the virulence
of kdhAB bacteria may be related to this early innate immune
response.Indeed,severalstudieshaveshownthatelicitinganearly
inﬂammatory response in mice by priming the animals with an
agonist of TLR3, TLR4, or TLR9 enhances survival to F. tularensis
infection and decreases organ bacterial burdens (33–35).
Recent studies have indicated that Kdo residues contribute to
proinﬂammatory responses to LPS (36–38). Therefore, the pres-
ence of a side chain Kdo in the kdhAB mutant, with direct rec-
ognition of this modiﬁed LPS by the TLR2 signaling pathway, has
emerged as a potential mechanism for the observed phenotype.
However, our in vitro studies suggest that this is not the case, as
puriﬁed LPSs from the kdhAB mutant and LVS elicit similarly
weak NF-B activation (Fig. 4B). Another possible explanation is
that the structural alteration of LPS exposes one or more TLR2
ligandspresentonthebacterialsurface.Theelectrostaticchargeof
LPS is important for the folding of certain outer membrane pro-
teins (39–42), and Kdo—as a negatively charged sugar—contrib-
utes to the overall charge of LPS. Thus, the presence of an addi-
tional Kdo residue in kdhAB mutant LPS may alter the
conformation of the outer membrane, exposing TLR2 ligands
such as lipoproteins (43). In support of this idea, we showed that
FopA surface protein is more accessible to antibodies in the
kdhAB mutant than in parental LVS (Fig. 5B).
LVS is an attenuated F. tularensis subsp. holarctica strain (type
B) that was empirically derived in the former Soviet Union and
developed as a live attenuated vaccine against the highly virulent
F.tularensis.However,theLVS-basedvaccineremainsunlicensed
in the United States and several other nations for several reasons,
including the following: (i) an incomplete understanding of the
genetic basis for its attenuation; (ii) untoward reactions; and (iii)
FIG 5 Mutation in kdhAB leads to enhanced accessibility of the bacterial surface. (A)
Investigation of the leaky-membrane phenotype. Mid-logarithmic-phase cultures were
spread onto CHAH plates, and a 10-l volume of SDS (20, 10, and 5%) or EDTA (500,
250 and 125 mM) was spotted onto ﬁlter discs. Images were captured after 48 h of
bacterial growth. Black arrows indicate zone of inhibition around 6-mm ﬁlter discs. (B)
F. tularensis LVS and kdhAB and wbtA mutant strains were tested for binding of
mouse anti-FopA antibodies to their surface FopA proteins in an antigen accessibility
assay. Bacteria—along with surface-bound FopA antibodies—were lysed, and proteins
were resolved by 5 to 20% SDS-PAGE. Bound FopA antibodies were detected as IgG
heavy chain (HC) and IgG light chain (LC). Total FopA and bacterioferritin (Bfr) pro-
tein levels are shown as protein loading controls.
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mechanisms of LVS-mediated protection against tularemia in-
volve TLR2-dependent innate immunity (25–27). Therefore, an
LVS mutant that exhibits attenuated virulence in mice and more
strongly elicits activation of TLR2 signaling might prove to be a
safer and more effective vaccine candidate than the original LVS.
HereweshowthatthekdhABLVSmutantmaybesuchavaccine
candidate:itsvirulenceisattenuated,itsabilitytoactivateTLR2is
enhanced, and its protective efﬁcacy against F. tularensis type A
strainSchuS4issimilartothatofLVS.Mutantsunabletomodify
lipid A by carbohydrate incorporation were attenuated in mice,
activatedproinﬂammatoryresponses,andwereprotectiveagainst
F. tularensis subsp. novicida (8). However, protection against the
highly virulent F. tularensis type A strain Schu S4 has not been
investigated.Fewpreviouslyassessedmutantshavebeenshownto
induce protective immunity against type A strains (for a review,
see reference 44). These mutants have had deletions in genes in-
cludingFTT1103,FTT0918,sodB,wzy,andggt(45,46).Wereport
a new mutation that is relevant for tularemia vaccine design.
Herein we demonstrate that the two-component Kdo hydro-
lase KdhAB is involved in the virulence of F. tularensis LVS. A
kdhAB mutant is attenuated in mice, elicits a stronger proin-
ﬂammatorycytokineresponseinaTLR2-dependentmanner,and
induces protective immunity against the highly virulent Schu S4
strainofF.tularensis.OurdatasuggestthatanovelLPSmodiﬁca-
tion—theremovalofsidechainKdo—isimportantintheevasion
of innate immunity by F. tularensis. Kdo hydrolase is also pro-
duced by two other pathogens, H. pylori and L. pneumophila (14,
15, 17, 18). It will be particularly interesting to study the role of
this enzyme in the virulence of these organisms.
MATERIALS AND METHODS
Ethics statement. All work with animals was conducted according to the
recommendationsintheGuidefortheCareandUseofLaboratoryAnimals
(47). The protocol was approved by the Standing Committee on Animals
of the Harvard Medical Area (protocol 04723).
Bacterialstrainsandplasmids.FrancisellatularensisLVS(kindlypro-
vided by Karen Elkins, U.S. Food and Drug Administration, Bethesda,
MD)wasgrownincysteineheartagarsupplementedwith1%hemoglobin
(CHAH) for 72 h at 37°C and 5% CO2, in modiﬁed Muller-Hinton broth
(Becton, Dickinson, Franklin Lakes, NJ) supplemented with ferric pyro-
phosphate and IsoVitaleX (Becton, Dickinson, Franklin Lakes, NJ), or in
tryptic soy broth (Difco, Detroit, MI). Escherichia coli strain DH5 was
usedforgeneralcloningandwasgrowneitherinLuria-Bertani(LB)broth
oronLBagarplates.Whenappropriate,ampicillin(100g/ml)andkana-
mycin (50 g/ml) were added to broth medium, and kanamycin (10 g/
ml) was added to CHAH.
ConstructionoftheF.tularensisLVSkdhABdeletionmutant.The
kdhAB mutant was constructed by allelic exchange (48) by a procedure
described previously (14). The whole kdhA gene was deleted. As the last
FIG6 TheF.tularensiskdhABmutantstrainisnotalteredinthebiosynthesisofOantigenorlipidA.(A)SDS-PAGEanalysisofF.tularensisLVSandkdhAB
mutant outer membranes. LPS was visualized by zinc staining. (B) Negative-ion MALDI-TOF analysis of lipid A from LVS and kdhAB bacteria.
TABLE 1 Survival of WT C57BL/6, TLR2 /, and TLR4/ mice
21 days after an intranasal challenge with F. tularensis kdhAB mutant
Challenge
dose (CFU)
Survival rate (%) of mice:
C57BL/6
(n  10)
TLR2/
(n  10)
TLR4/
(n  5)
102 100 100 100
103 100 40 100
104 100 0 100
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also deleted. The following primers were used: 5=-ACCCCCGGGCACTT
TCGTGCTTAGATATCT-3=(XmaIsiteunderlined)and5=-TGTGGTAC
CAGTTTTAAAAATTAAGTAAGT-3= (KpnI site underlined) to amplify
the1-kbupstreamregion;5=-ACCGGTACCTAATTATAACCTTTTGAC
AAC-3= (KpnI site underlined) and 5=-TGTGAATTCGAAAGTAGGTG
ATATGATTGC-3= (EcoRI site underlined) to amplify the 1-kb down-
stream region.
For complementation studies, plasmid pkdhAB encoding kdhAB
genesunderagroELpromoterwasconstructed.Inbrief,aDNAsequence
containing open reading frames of both kdhA and kdhB genes was ampli-
ﬁed by PCR with primers 5=-TGGAATTCATGAAACATAAACTAAAGC
TAG-3= (EcoRl site underlined) and 5=-TCCTCGAGTTAGTAATATAT
AATCTTATCTT-3= (Xhol site underlined). After restriction endo-
nuclease digestion, the kdhAB DNA fragment was ligated into the EcoRI
and XhoI sites of plasmid pTH17 (49).
Bacterial DNA/RNA preparation. Plasmids were introduced into
F. tularensis LVS by electroporation, and miniplasmids for E. coli DH5
and F. tularensis LVS were prepared with a QIAprep spin miniprep kit
according to the manufacturer’s instructions (Qiagen, Venlo, Nether-
FIG7 Bacteria of the F. tularensis LVS kdhAB mutant strain elicit protective immunity against F. tularensis LVS and type A strain Schu S4. (A and B) Groups
of BALB/cByJ mice (10 mice in each group) were immunized intranasally with 3 doses of LVS or kdhAB bacteria; 28 days after the last dose, the mice were
challenged intranasally with either 104 CFU of LVS (10  LD50) (A) or 10 CFU of strain Schu S4 (10  LD50) (B). (C) Hematoxylin and eosin (H&E) staining
of liver tissue on day 5 after Schu S4 challenge. The black arrowhead indicates extensive tissue necrosis (10). (D) Bacterial burden in lung, spleen, and liver of
mice 5 days after Schu S4 challenge (mean plus SD; n  3). (E) Titers of serum antibody to F. tularensis LPS were determined by ELISA. Sera from LVS-
immunized, kdhAB mutant-immunized, and unimmunized control mice were collected on the day before challenge. ELISA was performed as described in
Materials and Methods.
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chasedfromNewEnglandBiolabs.DNAligationsandtransformations
of chemically competent E. coli were performed by standard protocols
(50).
LPSpuriﬁcation.LPSwaspuriﬁedfromF.tularensisWTandkdhAB
strains as described elsewhere (49). A modiﬁcation of the hot phenol-
water method was used (51).
Mouse infection and immunization studies. Male BALB/cByJ,
C57BL/6, TLR2/, and TLR4/ speciﬁc-pathogen-free mice (6 to 8
weeks old; Jackson Laboratory, Bar Harbor, ME) were housed in an ani-
malfacilityatHarvardMedicalSchool.Allproceduresconformedtopro-
tocols approved by the Institutional Animal Care and Use Committee.
Bacterial virulence was assessed by intranasal challenge of BALB/cByJ
mice(n6)with103CFUofF.tularensisLVSbacteriaorwith103,10 4,or
105 CFU of kdhAB bacteria (inoculum volume, 50 l per mouse). Mice
were lightly anesthetized with isoﬂurane (Baxter, Deerﬁeld, IL). The im-
portanceoftheTLR2signalingpathwayinmousesurvivalafterintranasal
challenge with kdhAB mutant bacteria (102,1 0 3,o r1 0 4 CFU) was as-
sessed in C57BL/6 WT, TLR2/, and TLR4/ mice. In all these in-
stances, survival was monitored over a 26-day period unless otherwise
indicated.
For immunization studies, groups of BALB/cByJ mice (n  10) were
immunized by the intranasal route with three doses of bacteria at 2-week
intervals;thedoseswere10,10,and102CFUforF.tularensisLVSand103,
104, and 105 CFU for the kdhAB mutant. A mock immunization group
that received PBS served as a control. Four weeks after the last dose, mice
were challenged intranasally with either 104 CFU of LVS (10  LD50)o r
10 CFU of strain Schu S4 (10  LD50). Mice were challenged with the
F. tularensis Schu S4 strain at the animal biosafety level 3 (ABSL3) core
facility at Harvard Medical School. Titers of serum antibody to LPS were
measured by ELISA as described previously (26).
Organ bacterial burden and histopathology. BALB/cByJ mice were
challengedintranasallywith103CFUofF.tularensisLVSorkdhABbac-
teria. Six days after infection, mice were killed, blood was collected, and
tissues were weighed, hand mashed, and homogenized with a Stomacher
80-paddle action blender (Seward, Port Saint Lucie, FL). Serial 10-fold
dilutions were prepared with sterile 1 PBS supplemented with 2% fetal
bovine serum. A 10-l volume of each dilution was plated onto CHAH
plates and incubated at 37°C in 5% CO2 until colonies became visible
(~72h).DatawereexpressedasCFUpergramoftissueorpermilliliterof
blood.
Histological analysis was performed on the livers of F. tularensis Schu
S4-challenged mice that had been immunized with F. tularensis LVS or
kdhAB mutant or had been given PBS as a control. Livers from each
groupofmicewereﬁxedin10%formalinsolution,embeddedinparafﬁn,
and stained with hematoxylin and eosin after sectioning.
Bronchoalveolar lavage. BALB/cByJ mice were challenged intrana-
sallywith103CFUofF.tularensisLVSorkdhABbacteria.After24h,the
mice were killed, the tracheae were exposed, and the lungs were lavaged
with 0.5 ml of PBS supplemented with 0.5 mM EDTA. TNF- and IL-1
were assayed with ELISA Duoset kits (R&D Systems, Minneapolis, MN).
BMMinfectionandmeasurementsofcytokineproductionandgene
expression. Bone marrow was ﬂushed with PBS from the femurs of
C57BL/6Jmice(6to8weeksold;JacksonLaboratory),spundown,resus-
pended in BMM growth medium (Dulbecco modiﬁed Eagle medium
[DMEM] containing D-glucose [4.5 mg/liter], L-glutamine [4 mM], and
sodium pyruvate [110 mg/liter] [Invitrogen, Carlsbad, CA] supple-
mented with 10% heat-inactivated fetal bovine serum [FBS] [Invitrogen]
and 30% cell line L929-conditioned DMEM with nonessential amino ac-
ids). The cells from each femur were plated in two deep petri dishes, and
theplateswereincubatedat37°Cin5%CO2inthepresenceofgentamicin
(50g/ml).After3days,BMMgrowthmediumwasaddedtopetridishes.
The cells were incubated for an additional 2 to 3 days.
For measurements of cytokine release, BMMs were seeded in 24-well
plates at a density of 5  105 cells/well, and the plates were incubated at
37°C in 5% CO2 overnight. The macrophages were then infected with
mid-logarithmic-phaseF.tularensisLVSorkdhABbacteriaatanMOIof
10,20,or50(ratioofbacteriatomacrophages)for24h.TNF-andIL-1
in cell supernatants were measured with ELISA Duoset kits according to
the manufacturer’s recommendations (R&D Systems).
For measurements of gene expression, BMMs were seeded in 6-well
plates at a density of 2  106 cells/well, and the plates were incubated at
37°C in 5% CO2 overnight. The macrophages were then infected with
mid-log F. tularensis LVS or kdhAB bacteria at an MOI of 10. At various
time points, cells were lysed in 0.4 ml TRIzol (Invitrogen), and RNA was
isolated according to the manufacturer’s instructions. Reverse transcrip-
tion was performed with a qScript Flex cDNA synthesis kit (Quanta Bio-
sciences, Gaithersburg, MD) according to the manufacturer’s instruc-
tions. Real-time PCR was conducted with Perfecta SYBR green supermix
(Quanta Biosciences) in a Bio-Rad iCycler iQ system (45 cycles, with 1
cycle consisting of 15 s at 95°C, 45 s at 60°C, and 30 s at 72°C). Gene
expression was normalized to the expression of the RNA polymerase II
(RP II) gene, which is considered a stably expressed housekeeping gene
(52). The following primer sets were used: for TNF-, sense (5=-TATGG
CTCAGGGTCCAACTC-3=)andantisense(5=-CTCCCTTTGCAGAACT
CAGG-3=);forIL-1,sense(5=-GGGCCTCAAAGGAAAGAATC-3=)and
antisense (5=-TACCAGTTGGGGAACTCTGC-3=); and for RP II, sense
(5=-GCACCACGTCCAATGATAT-3=) and antisense (5=-CTGGCGGTT
GACCCCATGAC-3=). Relative gene expression was calculated by the
CT method (53) and reported as fold induction over the uninfected
control level (mean  standard deviation [SD] values for samples from
three independent experiments).
Murine macrophage-like cell line infection. WT, Unc93B/,
MyD88/, TLR4/, and TLR2/ murine macrophage-like cell lines,
kindly provided by Douglas T. Golenbock (University of Massachusetts
Medical School, Worcester, MA), were seeded in 24-well plates at a den-
sity of 5  105 cells/well, and the plates were incubated overnight at 37°C
in5%CO2.Themacrophagesweretheninfectedwithmid-logF.tularen-
sisLVSorkdhABbacteriaatanMOIof100.After2h,cellswerewashed
three times with Dulbecco’s PBS and lysed in 60 l of lysis buffer (kit
BF14100; R&D Systems). IL-1 in lysates was measured with an ELISA
Duoset kit (R&D Systems).
NF-B reporter luciferase assay. Stable HEK293 cell lines expressing
TLR2 receptor were kindly provided by Douglas T. Golenbock. HEK-
TLR2 and HEK-TLR4/MD2 cells were seeded into 12-well tissue culture
plates at a density of 3  105 cells/well. The following day, cells were
transiently transfected with luciferase reporter genes; Genejuice (EMD
Chemicals, Darmstadt, Germany) was used per the manufacturer’s rec-
ommendations.ToassessNF-Bactivation,anNF-Bluciferasereporter
gene (consisting of an artiﬁcial promoter NF-B site driving the ﬁreﬂy
luciferase gene) was cotransfected with a constitutively active Renilla lu-
ciferase reporter gene, phRL-TK (Promega, Fitchburg, WI); phRL-TK
was used to normalize transfection efﬁciency. The following day, the cells
were stimulated as indicated in Results. During stimulation with LPSs
fromF.tularensisLVSorkdhABbacteria,themixturecontainedsoluble
CD14recombinantprotein(5g/ml)(ProSciInc.,Poway,CA).After24h
of stimulation, the cells were lysed in passive lysis buffer (Promega), and
reporter gene activity was measured with a plate reader luminometer
(Victor2; PerkinElmer Life Sciences) and the Dual-Luciferase reporter
assay system (Promega).
Surfaceantigen-bindingassay.EvaluationofFopAantibodybinding
to the bacterial surface was performed as described previously (24), with
some modiﬁcations. In brief, cultures of WT F. tularensis LVS, kdhAB,
and wbtA bacteria were grown overnight in brain heart infusion (BHI)
broth.CulturesweredilutedinfreshBHImediumtoanopticaldensityat
620 nm (OD620) of 0.07, and bacteria were further grown to an OD620 of
0.5.Afterthebacteriawereharvested,6108bacteriafromeachstrain(in
a 50-l volume) were mixed with monoclonal FopA antibodies (ﬁnal
concentration,0.1mg/ml)(54)inPBScontaining0.1%glucoseand0.5%
bovine serum albumin (BSA). After incubation for1ha t37°C, bacteria
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wash, pellets were resuspended in Laemmli sample buffer (Bio-Rad, Her-
cules, CA). Protein samples were resolved on 5 to 20% Protean TGX gels
(Bio-Rad) and transferred to nitrocellulose membranes. Alkaline phos-
phatase (AP)-conjugated rabbit anti-mouse antibody (Abcam, Cam-
bridge, MA) was used to detect heavy- and light-chain subunits of bound
FopA antibodies.
LPS analysis by SDS-PAGE and MALDI-TOF mass spectrometry.
Outer membranes from F. tularensis LVS and kdhAB bacteria were iso-
lated, resolved by Tricine SDS-PAGE, and stained with zinc as previously
described (14). Lipid A from LVS and kdhAB bacteria was isolated and
analyzed by negative-ion matrix-assisted laser desorption ionization-
time of ﬂight (MALDI-TOF) mass spectrometry (14).
Dataanalysis.Dataareexpressedasmeanstandarddeviation(SD)
values.UnpairedStudent’sttestwasusedforstatisticalanalysis.APvalue
of 0.05 was considered signiﬁcant.
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